NYSE:LOMA • US54150E1047
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for LOMA NEGRA CIA IND-SPON ADR (LOMA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-06-18 | Citigroup | Initiate | Buy |
| 2025-05-20 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2025-04-23 | B of A Securities | Upgrade | Neutral -> Buy |
| 2024-04-08 | B of A Securities | Upgrade | Underperform -> Neutral |
| 2024-04-04 | UBS | Downgrade | Neutral -> Sell |
| 2023-11-16 | UBS | Maintains | Neutral -> Neutral |
| 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 145.133B 1.14% | 422.161B 190.88% | 699.179B 65.62% | 859.454B 22.92% | 1.082T 25.84% | |
| EBITDA YoY % growth | 38.894B -10.67% | 96.072B 147.01% | 172.034B 79.07% | 283.62B 64.86% | 359.082B 26.61% | |
| EBIT YoY % growth | 25.616B -19.78% | 63.881B 149.38% | 109.407B 71.27% | 154.702B 41.40% | 270.393B 74.78% | |
| Operating Margin | 17.65% | 15.13% | 15.65% | 18.00% | 25.00% | |
| EPS YoY % growth | N/A -135.71% | N/A 2,822.22% | N/A 8.44% | 13,118.08 3,095.98% | 33,948.80 158.79% |
All data in ARS
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in ARS
LOMA NEGRA CIA IND-SPON ADR (LOMA) will report earnings on 2026-05-04.
The number of analysts covering LOMA NEGRA CIA IND-SPON ADR (LOMA) is 9.